Global Study Finds Stark Differences in Maternal RSV Vaccine Uptake

Low uptake limits benefits of maternal RSV vaccination

Vaccination against a common respiratory virus during pregnancy lowers the risk of severe disease in babies by 74 per cent, but uptake in many countries remains low, a new review suggests.

Global study finds stark differences in maternal RSV vaccine uptake

Vaccination against a common respiratory virus during pregnancy lowers the risk of severe disease in babies by 74%, but uptake in many countries remains low, a new review suggests. The report also reveals evidence of lower uptake of the respiratory syncytial virus (RSV) vaccine among some socioeconomic and ethnic groups, those with reduced access to health care and younger mothers.

Maternal RSV vaccine shields babies but global uptake lags far behind

A systematic review of more than four million pregnancies finds maternal RSV vaccination cuts severe infant disease by 74 per cent, yet coverage remains low and uneven across countries and communities.